UBS Group’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.75M | Buy |
|
|||||
|
2025
Q2 | $3.95M | Sell |
|
|||||
|
2025
Q1 | $3.86M | Sell |
|
|||||
|
2024
Q4 | $7.7M | Buy |
|
|||||
|
2024
Q3 | $5.07M | Buy |
|
|||||
|
2024
Q2 | $2.99M | Sell |
|
|||||
|
2024
Q1 | $5M | Buy |
|
|||||
|
2023
Q4 | $41.3K | Sell |
|
|||||
|
2023
Q3 | $1.49M | Sell |
|
|||||
|
2023
Q2 | $2.05M | Sell |
|
|||||
|
2023
Q1 | $1.97M | Sell |
|
|||||
|
2022
Q4 | $2.59M | Buy |
|
|||||
|
2022
Q3 | $415K | Sell |
|
|||||
|
2022
Q2 | $1.75M | Buy |
|
|||||
|
2022
Q1 | $1.34M | Sell |
|
|||||
|
2021
Q4 | $6.09M | Buy |
|
|||||
|
2021
Q3 | $4.33M | Buy |
|
|||||
|
2021
Q2 | $687K | Sell |
|
|||||
|
2021
Q1 | $1.36M | Buy |
|
|||||
|
2020
Q4 | $52K | Buy |
|
|||||
|
2020
Q3 | $7K | Sell |
|
|||||
|
2020
Q2 | $150K | Sell |
|
|||||
|
2020
Q1 | $126K | Buy |
|
|||||
|
2019
Q4 | $102K | Sell |
|
|||||
|
2019
Q3 | $1.83M | Buy |
|
|||||
|
2019
Q2 | $280K | Buy |
|
|||||
|
2019
Q1 | $310K | Sell |
|
|||||
|
2018
Q4 | $2.83M | Buy |
|
|||||
|
2018
Q3 | $1.92M | Buy |
|
|||||
|
2018
Q2 | $647K | Sell |
|
|||||
|
2018
Q1 | $7.17M | Buy |
|
|||||
|
2017
Q4 | $1.67M | Sell |
|
|||||
|
2017
Q3 | $3.29M | Buy |
|
|||||
|
2017
Q2 | $1.98M | Buy |
|
|||||
|
2017
Q1 | $252K | Sell |
|
|||||
|
2016
Q4 | $2.49M | Buy |
|
|||||
|
2016
Q3 | $1.86M | Sell |
|
|||||
|
2016
Q2 | $1.65M | Buy |
|
|||||
|
2016
Q1 | $214K | Sell |
|
|||||
|
2015
Q4 | $5.13M | Buy |
|
|||||
|
2015
Q3 | $396K | Sell |
|
|||||
|
2015
Q2 | $625K | Sell |
|
|||||
|
2015
Q1 | $594K | Sell |
|
|||||
|
2014
Q4 | $16.6M | Buy |
|